Literature DB >> 11749864

Development of a K562 cell-based assay for screening anticancer agents.

J Qian1, C H Zhou, Z Qian, F J Nan, Q Z Ye.   

Abstract

AIM: To develop a leukemia cell line K562-based assay for high-throughput screening.
METHODS: The screening was carried out on 96-well plates with monitoring cell proliferation by a combined 3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium (MTS)/phenazine methosulfate (PMS) method. Conditions for evaluating effects on the proliferation of K562 cells by individual compounds on the 96-well plates were optimized.
RESULTS: A set of 800 small organic compounds was screened for anticancer activity by this cell-based assay, with consumption of each compound at 500 ng. Eleven compounds were identified with >80 % inhibitory activity at 5 mg/L, among which 9 compounds were confirmed by subsequent testing at multiple concentrations. The most potent compound showed an IC50 at 170 nmol/L, and there were total of 7 compounds showed IC50 less than 10 micromol/L.
CONCLUSION: The high-throughput method using K562 cell line is fast, economical, effective, and practical in identifying inhibitors as potential therapeutic agents for cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749864

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  1 in total

1.  In vitro studies of the anticancer action of Tectaria cicutaria in human cancer cell lines: G0/G1 p53-associated cell cycle arrest-Part I.

Authors:  Preeti Gajendra Karade; Namdeo Ramhari Jadhav
Journal:  J Tradit Complement Med       Date:  2017-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.